BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33108450)

  • 21. PREDICTORS OF BIOCHEMICAL REMISSION AND RECURRENCE AFTER SURGICAL AND RADIATION TREATMENTS OF CUSHING DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Abu Dabrh AM; Singh Ospina NM; Al Nofal A; Farah WH; Barrionuevo P; Sarigianni M; Mohabbat AB; Benkhadra K; Carranza Leon BG; Gionfriddo MR; Wang Z; Mohammed K; Ahmed AT; Elraiyah TA; Haydour Q; Alahdab F; Prokop LJ; Murad MH
    Endocr Pract; 2016 Apr; 22(4):466-75. PubMed ID: 26789343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease.
    El Asmar N; Rajpal A; Selman WR; Arafah BM
    J Clin Endocrinol Metab; 2018 Feb; 103(2):477-485. PubMed ID: 29244084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrences of ACTH-secreting adenomas after pituitary adenomectomy can be accurately predicted by perioperative measurements of plasma ACTH levels.
    Abdelmannan D; Chaiban J; Selman WR; Arafah BM
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1458-65. PubMed ID: 23450054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Machine Learning Models for Predicting Postoperative Delayed Remission in Patients With Cushing's Disease.
    Fan Y; Li Y; Bao X; Zhu H; Lu L; Yao Y; Li Y; Su M; Feng F; Feng S; Feng M; Wang R
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e217-e231. PubMed ID: 33000120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.
    Ioachimescu AG
    Endocrinol Metab Clin North Am; 2018 Jun; 47(2):335-347. PubMed ID: 29754635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease.
    Uvelius E; Höglund P; Valdemarsson S; Siesjö P
    Pituitary; 2018 Oct; 21(5):490-498. PubMed ID: 30039432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years.
    Hofmann BM; Hlavac M; Martinez R; Buchfelder M; Müller OA; Fahlbusch R
    J Neurosurg; 2008 Jan; 108(1):9-18. PubMed ID: 18173305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of technique on cushing disease outcome using strict remission criteria.
    Alahmadi H; Cusimano MD; Woo K; Mohammed AA; Goguen J; Smyth HS; Macdonald RL; Muller PJ; Horvath E; Kovacs K
    Can J Neurol Sci; 2013 May; 40(3):334-41. PubMed ID: 23603168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.
    Esposito F; Dusick JR; Cohan P; Moftakhar P; McArthur D; Wang C; Swerdloff RS; Kelly DF
    J Clin Endocrinol Metab; 2006 Jan; 91(1):7-13. PubMed ID: 16234305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
    De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
    J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
    Erfe JM; Perry A; McClaskey J; Inzucchi SE; James WS; Eid T; Bronen RA; Mahajan A; Huttner A; Santos F; Spencer D
    J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.
    Wagenmakers MA; Boogaarts HD; Roerink SH; Timmers HJ; Stikkelbroeck NM; Smit JW; van Lindert EJ; Netea-Maier RT; Grotenhuis JA; Hermus AR
    Eur J Endocrinol; 2013 Sep; 169(3):329-37. PubMed ID: 23786985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the histological pseudocapsule in surgery for Cushing disease: rapid postoperative cortisol decline predicting complete tumor resection.
    Monteith SJ; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2012 Apr; 116(4):721-7. PubMed ID: 22283193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease.
    Srinivasan L; Laws ER; Dodd RL; Monita MM; Tannenbaum CE; Kirkeby KM; Chu OS; Harsh GR; Katznelson L
    Pituitary; 2011 Dec; 14(4):312-7. PubMed ID: 21298507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical predictors of outcome of pituitary surgery for Cushing's disease.
    Alwani RA; de Herder WW; van Aken MO; van den Berge JH; Delwel EJ; Dallenga AH; De Jong FH; Lamberts SW; van der Lely AJ; Feelders RA
    Neuroendocrinology; 2010; 91(2):169-78. PubMed ID: 19907141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.
    Leal-Cerro A; Martín-Rodríguez JF; Ibáñez-Costa A; Madrazo-Atutxa A; Venegas-Moreno E; León-Justel A; García-Hernández N; Luque RM; Castaño JP; Cano DA; Soto-Moreno A
    Endocrinol Nutr; 2014 Feb; 61(2):69-76. PubMed ID: 24183946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
    Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.